A groundbreaking collaboration between researchers at the University of Oregon and scientists from L'Oréal has resulted in the development of a sophisticated artificial skin model, poised to revolutionize skincare testing and advance treatments for damaged skin.
Published in the journal Advanced Functional Materials on March 7, the research unveils a cutting-edge bioengineered skin model that closely mimics the complexity of real human skin, complete with multiple layers and distinct cell types. This achievement, made possible by a novel 3D printing technique pioneered by Associate Professor Paul Dalton, represents a significant leap forward in tissue engineering.
Unlike previous attempts at artificial skin, which lacked the intricate layering found in real skin, the newly developed model boasts a two-layered structure separated by a membrane. This innovative design enables the replication of quality skin tissue at full thickness, enhancing its resemblance to natural human skin.
Central to the breakthrough is the development of plastic scaffolds that emulate the extracellular matrix, a vital network supporting cellular functions in the body. These scaffolds, created using Dalton's melt electrowriting technique, provide a porous yet finely structured foundation for cell growth, ensuring precise control over tissue formation.
Remarkably, the artificial skin can be grown in just 18 days, significantly faster than previous methods, making it more practical for commercial lab testing. Currently, L'Oréal is utilizing the model to evaluate cosmetics and skincare products, underscoring its potential for enhancing product safety and efficacy assessments.
Looking ahead, researchers envision a multitude of applications beyond skincare, including wound healing for diabetic ulcers and skin grafts for burn patients. Moreover, the versatile scaffolds developed in this study hold promise for addressing various biomedical challenges, from regenerating damaged nerves to engineering artificial blood vessels.
Importantly, the materials used in the scaffold are FDA-approved for use in the human body, facilitating the translation of this research into real-world medical solutions. With state-of-the-art fabrication facilities at the Knight Campus, the scalability of production is within reach, positioning this innovation to impact global research efforts in tissue engineering and beyond.
As the field of bioengineering continues to evolve, the development of this advanced artificial skin underscores the transformative potential of interdisciplinary collaboration in driving medical advancements and improving patient outcomes.
More: https://medicalxpress.com/news/2024-03-realistic-artificial-skin-medical-advances.html
